FAROOQ, A.; ZULFIQAR, B.; ASGHAR, K. Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma. Journal of Cancer & Allied Specialties, v. 9, n. 1, 30 Sep. 2022.